Isaac Barchas

Isaac Barchas was the founder of Eradivir, Inc., founded in 2020, holding the title of Director.
Mr. Barchas is also the founder of MorphImmune, Inc...
Mr. Barchas currently serves as Lead Independent Director at Immunome, Inc. since 2023.
Mr. Barchas is Director at Pecan Street, Inc., Novosteo, Inc., and Tetricus, Inc. Mr. Barchas is Managing Director at Arsenal Bridge Venture II LLC and Rbp Catalyst Fund 1.
Mr. Barchas is Founding Partner at Arsenal Bridge Ventures.
Formerly, Mr. Barchas was President & Chief Executive Officer at Research Bridge Partners from 2017 to 2024.
Mr. Barchas was Independent Director at Sustainable Opportunities Acquisition Corp.
from 2020 to 2021.
Mr. Barchas was Director at Austin Technology Incubator from 2006 to 2016.
Mr. Barchas was Board member at The Austin Chamber of Commerce from 2007 to 2009.
Mr. Barchas completed undergraduate studies at Stanford University in 1989.
Mr. Barchas earned graduate and doctorate degrees from The University of Chicago in 1993.